Ferris Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.2M Sell
9,359
-287
-3% -$34.6K 0.27% 81
2021
Q4
$1.19M Sell
9,646
-5
-0.1% -$654 0.26% 83
2021
Q3
$1.24M Buy
+9,651
New +$1.42M 0.27% 82
2021
Q2
Sell
-9,682
Closed -$1.5M 206
2021
Q1
$1.5M Hold
9,682
0.38% 68
2020
Q4
$1.45M Buy
9,682
+5
+0.1% +$706 0.41% 60
2020
Q3
$1.28M Buy
9,677
+13
+0.1% +$1.7K 0.41% 59
2020
Q2
$1.12M Buy
9,664
+12
+0.1% +$1.38K 0.4% 65
2020
Q1
$947K Sell
9,652
-86
-0.9% -$11.3K 0.42% 64
2019
Q4
$1.42M Hold
9,738
0.5% 56
2019
Q3
$1.3M Hold
9,738
0.47% 52
2019
Q2
$1.11M Hold
9,738
0.41% 62
2019
Q1
$1.21M Sell
9,738
-25
-0.3% -$2.84K 0.44% 57
2018
Q4
$983K Sell
9,763
-11
-0.1% -$1.24K 0.44% 55
2018
Q3
$1.25M Sell
9,774
-43
-0.4% -$5.11K 0.49% 44
2018
Q2
$1.06M Hold
9,817
0.45% 46
2018
Q1
$1.04M Sell
9,817
-2,765
-22% -$321K 0.42% 51
2017
Q4
$1.47M Buy
12,582
+3,914
+45% +$443K 0.52% 45
2017
Q3
$985K Hold
8,668
0.49% 48
2017
Q2
$1.08M Buy
+8,668
New +$1.03M 0.51% 41

Other funds holding ZBH

Ferris Capital's ZBH Position: Q1 2022 in Review

Ferris Capital reduced its Zimmer Biomet (ZBH) stake by 3% in Q1 2022, selling an estimated $34.6K and leaving 9,359 shares worth $1.2M. The position accounts for 0.27% of the portfolio, ranked #81.

Ferris Capital first reported a position in ZBH in Q2 2017 and has held it in 19 quarters since. The position peaked at $1.5M in Q1 2021. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Ferris Capital held 9,359 shares of Zimmer Biomet worth $1.2M as of Q1 2022.
  • Ferris Capital sold 287 Zimmer Biomet shares in Q1 2022, an estimated $34.6K.
  • Zimmer Biomet made up 0.27% of Ferris Capital's portfolio in Q1 2022, its #81 holding.
  • Ferris Capital first reported a position in Zimmer Biomet in Q2 2017 and has held it in 19 quarters since.
  • Ferris Capital's Zimmer Biomet position peaked at $1.5M in Q1 2021.
  • 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.